BioNotebook: Xoma, Endo, Adamis, CymaBay, Theratechnologies

Xoma offering will gross $50m; Endo sells notes to refinance debt; Adamis splits stock, raises $22.1m; CymaBay closes $38.2m in financing; and Theratechnologies regains Egrifta.

Xoma offering will gross $50m; Endo sells notes to refinance debt; Adamis splits stock, raises $22.1m; CymaBay closes $38.2m in financing; and Theratechnologies regains Egrifta.

Xoma sells 9.5m shares to fund gevokizumab, XMet platform

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category